Penserra Capital Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Penserra Capital Management’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,090	Closed	-$36K	–	1581
2021 Q2	$36K	Buy	1,090 +5	+0.5%	+$127	﹤0.01%	1072
2021 Q1	$25K	Sell	1,085 -5	-0.5%	-$151	﹤0.01%	935
2020 Q4	$31K	Buy	+1,090	New	+$27.4K	﹤0.01%	774

Penserra Capital Management's CNST Position: Q3 2021 in Review

Penserra Capital Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 1,090 shares — an estimated $36K sold.

Penserra Capital Management first reported a position in CNST in Q4 2020 and held it in 3 quarters. The position peaked at $36K in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Penserra Capital Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Penserra Capital Management sold 1,090 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $36K.
Penserra Capital Management first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2020 and held it in 3 quarters.
Penserra Capital Management's Constellation Pharmaceuticals, Inc. position peaked at $36K in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Penserra Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.